Objective: To reevaluate the frequency and pattern of complementary and integrative medicine (CIM) use in patients with fibromyalgia (FM). Patients and Methods: Consecutive patients with FM who were referred to the Mayo Clinic fibromyalgia treatment program from January 5 through July 27, 2017, were invited to complete a survey about their use of CIM therapies in the preceding 6 months. The survey asked about 3 primary CIM domains: treatments and techniques, vitamins and minerals, and herbs and other dietary supplements. For direct comparative purposes, we reused the survey instrument from our prior analogous study of CIM use, performed in 2003. 
F ibromyalgia (FM) is a syndrome characterized by chronic widespread musculoskeletal pain that is often associated with unrefreshing sleep, stiffness, fatigue, cognitive difficulty, and psychological distress. 1 The cause of FM is unknown. A recent study has suggested that FM is a disorder of pain regulation or a form of central sensitization. 2 Fibromyalgia is the second most common disorder seen in rheumatologic practices, 3, 4 with an estimated prevalence of 2% to 8%. In the United States, more than 11.28 cases per 1000 women and 6.88 cases per 1000 men are diagnosed annually. 5e8 Currently, FM is diagnosed on the basis of a composite score of a patient's presenting symptoms; the previous diagnostic criterion of a specific number of tender points is no longer required.
9e11 Furthermore, with its diverse range of symptoms, FM markedly affects overall quality of life. 12e14 At present, FM has no known cure; treatment options aim to improve overall functioning and reduce symptom burden. 15, 16 Fibromyalgia is widely known to respond better to a multimodal treatment approach that includes medication and nonmedication treatment options. 1 However, despite numerous recent advances in treatment strategies, many patients still have long-term pain and therefore continue to explore other treatments, including complementary and integrative medicine (CIM) options.
According to the US Department of Health and Human Services, in collaboration with the Centers for Disease Control and Prevention and the National Center for Health Statistics, use of CIM therapies remains high, and according to their 2018 report, it is increasing in the United States in general 17, 18 and among persons with musculoskeletal pain disorders. Several evidence-based research studies and reviews have described the use and promising results of various CIM treatments as ancillary strategies for patients with FM, 19e24 and in 2003, our group surveyed patients with FM and reported a high prevalence (98%) of CIM use. 25 However, to our knowledge, no studies have compared the trends of CIM use in this patient population. To address this gap, we conducted a comparative study among a cohort of patients with FM seen at an academic, referral-based medical center. The aim of this study was to reevaluate the frequency and usage pattern of CIM therapies among patients with FM and to compare the current results with the trends observed in our 2003 study. 25 
PATIENTS AND METHODS
This study was approved by the Mayo Clinic Institutional Review Board.
Diagnosis and FM Treatment Program
Patients underwent an initial evaluation by a registered nurse, specifically trained in FM, in collaboration with a physician. A diagnosis of FM was established by using the American College of Rheumatology 1990 and 2010 criteria. 9, 11 If FM was confirmed, the patient was then enrolled in the Mayo Clinic FM treatment program (FTP) (Rochester, Minnesota). Our 2003 study used the 1990 diagnostic criteria for FM. Since the publication of the 2010 diagnostic criteria, the Mayo FTP has used both sets of criteria in clinical practice. The American College of Rheumatology has since published a 2016 revision, 10 but the FTP is currently still in the process of integrating these criteria into clinical practice; thus, cases diagnosed by the most recent criteria were not included in the current study.
The Mayo Clinic FTP is a 1.5-day multidisciplinary outpatient treatment program, staffed by physicians from the Division of General Internal Medicine. Access to this program is limited to patients who are referred by other Mayo Clinic physicians or their local primary care physicians. The FTP consists of group and individual sessions that are taught by a core group of registered nurses, general internists, physical therapists, occupational therapists, psychiatrists, psychologists, and ancillary staff. The primary aims of the FTP are to educate patients, improve physical and mental health functioning, provide evidencebased treatment options, and create a lasting treatment regimen.
Patients and Survey Instrument
Consecutive patients referred to the Mayo Clinic FTP from January 5 through July 27, 2017, were individually invited to complete a survey about their use of CIM therapies in general during the preceding 6 months. The survey asked about 3 primary domains: treatments and techniques (21 questions), vitamins and minerals (12 questions), and herbs and other dietary supplements (52 questions). For direct comparative purposes, we reused the survey instrument from our prior study (February 1 through July 31, 2003) . 25 Patients were instructed to respond "yes," "no," or "I don't know what [this option] is" for each potential CIM option, in accordance with their usage during the previous 6 months. The 
RESULTS

Demographic Characteristics
Of 407 patients invited to participate in the study, 310 (76.2%) completed the survey (Figure 1) (Table) .
Treatments and techniques used by at least 10% of respondents from the 2017 survey are reported in the Table. Other less frequently reported treatments and techniques were chelation therapy, dance therapy, and hypnosis.
Vitamins and Minerals
Approximately three-quarters of patients in the current cohort (73.5% [228 of 310]) reported using at least one vitamin or mineral, less than the 83% (240 of 289) who reported consuming them in the previous study (P<.0001). The use of vitamin E decreased 
Most Frequently Used CIM Modalities by Generations
We identified the 10 most common CIM modalities for respondents to the 2003 and 2017 surveys. We ranked these modalities within each generational category, with generations defined as follows: young adults (18-34 years), middle-aged adults (35-54 years), and older adults (>54 years). Figure 3 depicts the most common modalities for each surveyed year, ranked from most to least common within each generation.
In 2017, massage and spiritual healing were among the top 3 modalities for each generational category. In 2003 and 2017, massage, spiritual healing, chiropractic treatments, exercise for a specific medical problem, vitamin B complex, and magnesium were consistently used among all generations. In 2017, melatonin use was more popular among millennials.
DISCUSSION
To our knowledge, this report describes the first study comparing similarities and differences in the prevalence and patterns of CIM use among patients with FM over an extended (14-year) period. This study documents the prevalence of CIM use in 2017 (among various age groups and generational categories) and shows that use of many types of CIM increased from 2003 levels. By using our previously published methods and survey instrument, we had the unique opportunity not only to assess the current climate of CIM use among patients with FM but also to directly measure any changes that occurred during the interval period. When comparing the results of our 2003 and 2017 surveys, we noted several major differences in use, which spanned all 3 CIM domains (treatments and techniques, vitamins and minerals, and herbs and other dietary supplements).
We noted a significant increase in the proportion of respondents who used at least one treatment or technique (P<.0001) (Supplemental Table 1 , available online at http://www.mcpiqojournal.org). Specifically, we noted significant increases in the use of art therapy, aromatherapy, and homeopathic medicine (all P<.0001). We noted other increases (relaxation therapy, acupuncture, and magnetic therapy), but they were not statistically significant changes (P¼.002, P¼.003, and P¼.004, respectively). Art therapy, an emerging integrative and stimulating therapy option for various pain-related conditions, has demonstrated benefits for improving pain, quality of life, and psychological outcomes.
26e28 Aromatherapy has been identified by a survey study of patients with FM as one of the most effective adjunctive treatment options (90% of patients surveyed reported effectiveness of aromatherapy on their overall FM symptoms); 29 thus, it has been suggested as an integrative therapy. 30 Several clinical trials of aromatherapy have reported successful pain management in various patient groups, 31e33 and a systematic review reported that aromatherapy can be used successfully in pain management (evidenced by a significant reduction in reported pain on a visual analog scale) as an integrative adjunct to conventional treatments. 34 This systematic review further noted that aromatherapy more effectively treated nociceptive and acute pain compared with inflammatory or chronic pain. 34 Mixed results have been reported for homeopathic treatments. Some review data have suggested potential health benefits from homeopathy in FM (specifically as it pertains to tender point count, pain intensity, and fatigue), 35 but another study was unable to draw any definitive conclusions. 36 In terms of vitamins and minerals, we observed major changes in the use of several vitamins (Supplemental Table 2 , available online at http://www.mcpiqojournal.org). Specifically, we noted a significant increase in the use of vitamin B complex (P¼.0002) and a significant decrease in the use of vitamin E (P<.0001). This latter finding is a prime example of the direct impact of research on patient-directed self-care. Vitamin E use declined as evidence increasingly suggested that it did not have a beneficial role in cancer or cardiovascular diseases and might be associated with numerous medication interactions. 37 We observed a notable increase in the use of herbal or dietary supplements (Supplemental Table 3 , available online at http://www.mcpiqojournal.org). Specifically, we noted significant increases in the use of melatonin, fish oil, garlic, ginger, and flaxseed (all P<.0001). We further noted nonsignificant increases in the use of green tea (P¼.003), acidophilus (P¼.0005), and Llysine (P¼.001) and a decrease in the use of chondroitin (P¼.004). Melatonin has antinociceptive, anti-inflammatory, and analgesic properties and has an important role in the pathophysiology of pain; 38e40 therefore, it may be an effective tool in the management of FM-related musculoskeletal pain. 41, 42 In reserpine-induced FM in rats, melatonin reduced oxidative stress, inflammatory musculoskeletal changes, and difficulties with motor activity. 41 The efficacy of melatonin in humans with FM has been documented in several clinical trials (reduced tender point count, severity of pain, and Fibromyalgia Impact Questionnaire score; improved sleep quality), with a high level of confirmation 38,43e45 and limited adverse effects. 38 For fish oil, studies of nationally representative samples have revealed substantial use among middle-aged women. 46 In fact, the prevalence of fish oil use increased by 4-fold among older adults during a 5-year period. 47 Although investigators have obtained some promising results for fish oil as an adjuvant therapy in rheumatoid arthritis 48, 49 and neuropathic pain management, 50 more research is needed to evaluate its efficacy for FM symptom management. Ginger, with its analgesic and antiinflammatory properties, has been widely used for more than 2500 years.
51e56 Several studies have reported the efficacy of ginger in various inflammatory and pain-related conditions, and the authors of those studies recommend it as a suitable supplementary agent. 57e59 In an experimental mouse model of FM, ginger improved numerous FM-related symptoms, including allodynia, hyperalgesia, cognitive disturbances, anxiety, and depression. 53 Garlic also has anti-inflammatory and analgesic properties and has been widely used since the Middle Ages. A recent review described numerous potential medical uses for garlic that ranged from acute inflammatory conditions (arthritis and hepatic injury) to migraines and vascular diseases. 60, 61 Flaxseed, which contains fiber, has been consumed for thousands of years. Recent studies have documented its potential medical efficacy for constipation, hyperlipidemia, diabetes mellitus, and cancer. 62 The National Center for Complementary and Integrative Health is currently studying the potential role of flaxseed in inflammatory conditions. However, these studies and their results are quite heterogeneous, use different methodologies, and often have weak evidence supporting their conclusions. Furthermore, there is a paucity of data regarding the role and effectiveness of many of these herbal or dietary supplements, including ginger, garlic, or flaxseed, specifically in FM.
Importantly, the prevalence of any kind of CIM use among patients with FM was nearly 100%. Considering the trends in use over the 14 years between our 2 studies, we believe that CIM use is firmly rooted in our patients with FM and is here to stay. What originally began as "alternative" treatment options has slowly, with the aid of ongoing research, assimilated into conventional medical practice and is now considered "complementary" and "integrative." As such, it is imperative for health care professionals to be aware of these various treatment options and to be familiar with their associated basic efficacies, indications, and risks. Clinicians need to develop an effective strategy to screen patients for CIM use, assess CIMs for possible drug interactions, continually monitor for treatment efficacy (as would be done with all conventional treatments), and provide appropriate counsel. Two comprehensive online resources for clinicians include the National Center for Complementary and Integrative Health website (https://nccih.nih.gov) and the Natural Medicines Comprehensive Database (http://natural database.therapeuticresearch.com/home.aspx? cs¼&s¼ND).
Another interesting finding of this study is that the current use of various CIM modalities differed considerably between younger and older patients with FM (Supplemental  Tables 1-3 [available online at http://www. mcpiqojournal.org]) and across generational categories ( Figure 3 ). All generational categories of patients with FM reported increased CIM use overall compared with the 2003 cohort. The reasons underlying the high prevalence and increasing use of some CIM modalities in patients with FM is likely multifactorial, including the limited response to conventional treatment options, availability of CIM modalities, limited associated adverse effects, low cost, and the perplexing nature of FM symptoms, which often causes patients to seek other treatment options. 23,63e65 Our results also highlight that patients with FM are aware of and actively pursuing integrative medicine options, usually without the knowledge of their health care professional, due in part to the advancement of greater internet accessibility, improved evidence-based information available online, and online health informationeseeking behavior. 66e68 We hypothesize that the differences in rates of use of various CIM modalities across generational categories and age also are likely multifactorial. A recent study found that although the sociodemographic characteristics associated with CIM use overall was highest in female, middle-aged, and higher-educated individuals, these characteristics differed significantly by specific disease. 69 A subset analysis of that study concluded that people with musculoskeletal diseases use significantly greater CIM modalities across all sociodemographic variables (age, sex, educational level). 69 In contrast, we identified differences in CIM use rates among our FM cohort (based on age and generational category), which we hypothesize could be due to differences in age or generational familiarity, acceptance, and willingness to try certain CIM modalities; differences in exposure to various CIM options partly due to variable health information-seeking behavior and possible variations in health care professional or facility acceptance, endorsement, and availability of CIM modalities; and socioeconomic variables. Further studies should explore age and generational variations by using a large sample size and preferably qualitative methodologies.
We acknowledge some limitations to the study, which was a survey of referral-based patients at a single academic medical center.
Although we compared survey results of 2 similar cross-sectional groups, future longitudinal, multicenter studies with a larger sample size would provide better understanding of trends in CIM use. Our survey results may have some selection bias, with referral-based patients at an academic center potentially being more knowledgeable and accepting of CIM options compared with other population groups. Another limitation is the exclusion of several popular CIM modalities such as tai chi and yoga. We aimed to maintain consistency with our original 2003 survey, which also excluded those factors. Although we remained consistent in our methodology, we acknowledge that these omissions specifically could have affected our results, potentially leading to an even higher rate of CIM usage. Finally, highquality, controlled clinical trials with robust study designs are needed to identify the efficacy of CIM therapies for patients with FM.
CONCLUSION
Our results indicate a rising trend in the use of some CIM therapies among patients with FM across age and generational categories. Thus, it is imperative for health care professionals to be aware of and knowledgeable about these various modalities. In time, incorporation of these integrative options into a multifaceted treatment regimen may improve symptom management for patients with FM.
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